Advertisement

Topics

VIDEO: Women with osteoporosis had reduction in vertebral, nonvertebral fractures with abaloparatide, alendronate

02:01 EST 8 Nov 2017 | Healio

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Robin K. Dore, MD, spoke about results of the ACTIVExtend trial of postmenopausal women with osteoporosis. She said results showed that women who received abaloparatide for 18 months followed by 24 months of alendronate had a sustained decrease of vertebral and nonvertebral fractures compared to women who received placebo followed by alendronate.

Original Article: VIDEO: Women with osteoporosis had reduction in vertebral, nonvertebral fractures with abaloparatide, alendronate

NEXT ARTICLE

More From BioPortfolio on "VIDEO: Women with osteoporosis had reduction in vertebral, nonvertebral fractures with abaloparatide, alendronate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...